Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention

References

• Bachireddy, C., Soule, M. C., Izenberg, J. M., Dvoryak, S., Dumchev, K., & Altice, F. L. (2014). Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug and Alcohol Dependence, 134, 106–114.
   PubMed Web of Science ®Google Scholar
• Bonovas, S., & Nikolopoulos, G. (2012). High-burden epidemics in Greece in the era of economic crisis. Early signs of a public health tragedy. Journal of Preventive Medicine and Hygiene, 53(3), 169–171.
   PubMedGoogle Scholar
• Brenner, B. G., Roger, M., Routy, J.-P., Moisi, D., Ntemgwa, M., Matte, C., … Wainberg, M. A. (2007). High rates of forward transmission events after acute/early HIV-1 infection. The Journal of Infectious Diseases, 195(7), 951–959.
   PubMed Web of Science ®Google Scholar
• CDC – Centers for Disease Control and Prevention. (2008). Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e1030a1.htm
   Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365(6), 493–505.
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Shaw, G. M., McMichael, A. J., & Haynes, B. F. (2011). Acute HIV-1 infection. New England Journal of Medicine, 364(20), 1943–1954.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Mathers, B. M., Wirtz, A. L., Wolfe, D., Kamarulzaman, A., Carrieri, M. P., … Beyrer, C. (2014). What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. The International Journal on Drug Policy, 25(1), 53–60.
   PubMed Web of Science ®Google Scholar
• Duong, Y. T., Kassanjee, R., Welte, A., Morgan, M., De, A., Dobbs, T., … Parekh, B. S. (2015). Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes. PloS One, 10(2), e0114947.
   PubMed Web of Science ®Google Scholar
• Escudero, D. J., Lurie, M. N., Mayer, K. H., King, M., Galea, S., Friedman, S. R., & Marshall, B. D. L. (2017). The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: A modeling study. BMC Public Health, 17(1), 614.
   PubMedGoogle Scholar
• Friedman, S. R., Downing, M. J., Smyrnov, P., Nikolopoulos, G., Schneider, J. A., Livak, B., … Hatzakis, A. (2014). Socially-integrated transdisciplinary HIV prevention. AIDS and Behavior, 18(10), 1821–1834.
   PubMed Web of Science ®Google Scholar
• Gardner, L. I., Metsch, L. R., Anderson-Mahoney, P., Loughlin, A. M., del Rio, C., Strathdee, S., … Antiretroviral Treatment and Access Study Study Group. (2005). Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS (London, England), 19(4), 423–431.
   PubMed Web of Science ®Google Scholar
• Gourlay, A., Noori, T., Pharris, A., Axelsson, M., Costagliola, D., Cowan, S., … Porter, K. (2017). The human immunodeficiency virus continuum of care in European Union countries in 2013: Data and challenges. Clinical Infectious Diseases, 64(12), 1644–1656.
   PubMed Web of Science ®Google Scholar
• Green, N., Hoenigl, M., Chaillon, A., Anderson, C. M., Kosakovsky Pond, S. L., Smith, D. M., & Little, S. J. (2017). Partner services in adults with acute and early HIV infection. AIDS (London, England), 31(2), 287–293.
   PubMed Web of Science ®Google Scholar
• Hatzakis, A., Sypsa, V., Paraskevis, D., Nikolopoulos, G., Tsiara, C., Micha, K., … Des Jarlais, D. C. (2015). Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: The ARISTOTLE programme. Addiction, 110(9), 1453–1467.
   PubMed Web of Science ®Google Scholar
• Heimer, R., Usacheva, N., Barbour, R., Niccolai, L. M., Uusküla, A., & Levina, O. S. (2017). Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia. Addiction, 112(8), 1421–1431.
   PubMed Web of Science ®Google Scholar
• Helleberg, M., Häggblom, A., Sönnerborg, A., & Obel, N. (2013). HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps. PloS One, 8(8), e72257..
   PubMed Web of Science ®Google Scholar
• Hollingsworth, T. D., Anderson, R. M., & Fraser, C. (2008). HIV-1 transmission, by stage of infection. The Journal of Infectious Diseases, 198(5), 687–693.
   PubMed Web of Science ®Google Scholar
• Hull, M. W., & Montaner, J. S. G. (2013). HIV treatment as prevention: The key to an AIDS-free generation. Journal of Food and Drug Analysis, 21(4), S95–S101.
   PubMedGoogle Scholar
• Jackson, J. B., Musoke, P., Fleming, T., Guay, L. A., Bagenda, D., Allen, M., … Mmiro, F. (2003). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. The Lancet, 362(9387), 859–868.
   PubMed Web of Science ®Google Scholar
• Joseph, B., Kerr, T., Puskas, C. M., Montaner, J., Wood, E., & Milloy, M.-J. (2015). Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care, 27(9), 1128–1136.
   PubMed Web of Science ®Google Scholar
• Kerr, T., Hayashi, K., Ti, L., Kaplan, K., Suwannawong, P., & Wood, E. (2014). The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand. The International Journal on Drug Policy, 25(1), 171–174.
   PubMed Web of Science ®Google Scholar
• Knowlton, A. R., Arnsten, J. H., Eldred, L. J., Wilkinson, J. D., Shade, S. B., Bohnert, A. S., … Purcell, D. W. (2010). Antiretroviral use among active injection-drug users: The role of patient-provider engagement and structural factors. AIDS Patient Care and STDs, 24(7), 421–428.
   PubMed Web of Science ®Google Scholar
• Koopman, J. S., Jacquez, J. A., Welch, G. W., Simon, C. P., Foxman, B., Pollock, S. M., … Lange, K. (1997). The role of early HIV infection in the spread of HIV through populations. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association, 14(3), 249–258.
   PubMedGoogle Scholar
• Lourenço, L., Colley, G., Nosyk, B., Shopin, D., Montaner, J. S. G., Lima, V. D., & STOP HIV/AIDS Study Group (2014). High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada. PloS One, 9(12), e115277.
   PubMed Web of Science ®Google Scholar
• Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., Sharma, S., … Neaton, J. D. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, 373(9), 795–807.
   PubMed Web of Science ®Google Scholar
• Marzel, A., Shilaih, M., Yang, W.-L., Böni, J., Yerly, S., Klimkait, T., … Kouyos, R. D. (2016). HIV-1 Transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 62(1), 115–122.
   PubMed Web of Science ®Google Scholar
• Mehta, S. H., Kirk, G. D., Astemborski, J., Galai, N., & Celentano, D. D. (2010). Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996–2008. Clinical Infectious Diseases, 50(12), 1664–1671.
   PubMed Web of Science ®Google Scholar
• Meyer, J. P., Althoff, A. L., & Altice, F. L. (2013). Optimizing care for HIV-infected people who use drugs: Evidence-based approaches to overcoming healthcare disparities. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 57(9), 1309–1317.
   PubMed Web of Science ®Google Scholar
• Milloy, M.-J., Kerr, T., Bangsberg, D. R., Buxton, J., Parashar, S., Guillemi, S., … Wood, E. (2012). Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care and STDs, 26(1), 60–67.
   PubMed Web of Science ®Google Scholar
• Mizuno, Y., Purcell, D. W., Knowlton, A. R., Wilkinson, J. D., Gourevitch, M. N., & Knight, K. R. (2015). Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users. AIDS and Behavior, 19(4), 684–693.
   PubMed Web of Science ®Google Scholar
• Morgan, E., Skaathun, B., Nikolopoulos, G. K., Paraskevis, D., Williams, L. D., Smyrnov, P., … Schneider, J. A. (2018). A network intervention to locate newly HIV infected persons within MSM networks in Chicago. AIDS and Behavior, 23(1), 15–20.
   Web of Science ®Google Scholar
• Nikolopoulos, G. K., Katsoulidou, A., Kantzanou, M., Rokka, C., Tsiara, C., Sypsa, V., … Hatzakis, A. (2017). Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece. Epidemiology and Infection, 145(2), 401–412.
   PubMed Web of Science ®Google Scholar
• Nikolopoulos, G., Pavlitina, E., Muth, S. Q., Schneider, J., Psichogiou, M., Williams, L. D., … Friedman, S. R. (2016). A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP). Scientific Reports, 6(June), 38100.
   PubMedGoogle Scholar
• Nikolopoulos, G. K., Sypsa, V., Bonovas, S., Paraskevis, D., Malliori-Minerva, M., Hatzakis, A., & Friedman, S. R. (2015). Big events in Greece and HIV infection among people who inject drugs. Substance Use & Misuse, 50(7), 825–838.
   PubMed Web of Science ®Google Scholar
• Palepu, A., Tyndall, M. W., Chan, K., Wood, E., Montaner, J. S. G., & Hogg, R. S. (2004). Initiating highly active antiretroviral therapy and continuity of HIV care: The impact of incarceration and prison release on adherence and HIV treatment outcomes. Antiviral Therapy, 9(5), 713–719.
   PubMed Web of Science ®Google Scholar
• Paraskevis, D., Nikolopoulos, G., Fotiou, A., Tsiara, C., Paraskeva, D., Sypsa, V., … Hatzakis, A. (2013). Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: A longitudinal study. PloS One, 8(11), e78941.
   PubMed Web of Science ®Google Scholar
• Paraskevis, D., Paraschiv, S., Sypsa, V., Nikolopoulos, G., Tsiara, C., Magiorkinis, G., … Hatzakis, A. (2015). Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 35, 109–121.
   PubMed Web of Science ®Google Scholar
• Reddon, H., Milloy, M.-J., Simo, A., Montaner, J., Wood, E., & Kerr, T. (2014). Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS and Behavior, 18(4), 740–746.
   PubMed Web of Science ®Google Scholar
• Risher, K., Mayer, K. H., & Beyrer, C. (2015). HIV treatment cascade in MSM, people who inject drugs, and sex workers. Current Opinion in HIV and AIDS, 10(6), 420–429.
   PubMed Web of Science ®Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., … PARTNER Study Group. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181.
   PubMed Web of Science ®Google Scholar
• Skarbinski, J., Rosenberg, E., Paz-Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., … Mermin, J. H. (2015). Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Internal Medicine, 175(4), 588–596.
   PubMed Web of Science ®Google Scholar
• Smyrnov, P., Williams, L. D., Korobchuk, A., Sazonova, Y., Nikolopoulos, G. K., Skaathun, B., … Friedman, S. R. (2018). Risk network approaches to locating undiagnosed HIV cases in Odessa, Ukraine. Journal of the International AIDS Society, 21(1), 1–10.
   Google Scholar
• Sypsa, V., Psichogiou, M., Paraskevis, D., Nikolopoulos, G., Tsiara, C., Paraskeva, D., … Hatzakis, A. (2017). Rapid decline in HIV incidence among persons who inject drugs during a fast-track combination prevention program after an HIV outbreak in Athens. Journal of Infectious Diseases, 215(10), 1496–1505.
   PubMed Web of Science ®Google Scholar
• Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., … Nachega, J. B. (2012). Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: Evidence-based recommendations from an international association of physicians in AIDS care panel. Annals of Internal Medicine, 156(11), 817–833.
   PubMed Web of Science ®Google Scholar
• Van Beckhoven, D., Lacor, P., Moutschen, M., Piérard, D., Sasse, A., Vaira, D., … Goubau, P. (2014). Factors associated with the continuum of care of HIV-infected patients in Belgium. Journal of the International AIDS Society, 17(4 Suppl 3), 19534.
   PubMedGoogle Scholar
• Vasylyeva, T. I., Friedman, S. R., Lourenco, J., Gupta, S., Hatzakis, A., Pybus, O. G., … Magiorkinis, G. (2016). Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects. AIDS (London, England), 30(18), 2885–2890.
   PubMed Web of Science ®Google Scholar
• Westergaard, R. P., Ambrose, B. K., Mehta, S. H., & Kirk, G. D. (2012). Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: A survey of North American HIV providers. Journal of the International AIDS Society, 15(1), 10.
   PubMedGoogle Scholar
• Westergaard, R. P., Hess, T., Astemborski, J., Mehta, S. H., & Kirk, G. D. (2013). Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS (London, England), 27(16), 2559–2566.
   Google Scholar
• Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. Lancet (London, England), 376(9738), 355–366.
   PubMed Web of Science ®Google Scholar
• Wood, E., Hogg, R. S., Lima, V. D., Kerr, T., Yip, B., Marshall, B. D. L., & Montaner, J. S. G. (2008). Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA, 300(5), 550–554.
   PubMed Web of Science ®Google Scholar
• Wood, E., Milloy, M. J., & Montaner, J. S. G. (2012). HIV treatment as prevention among injection drug users. Current Opinion in HIV and AIDS, 7(2), 151–156.
   PubMed Web of Science ®Google Scholar
• Wood, E., Montaner, J. S. G., Yip, B., Tyndall, M. W., Schechter, M. T., O’Shaughnessy, M. V., & Hogg, R. S. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ : Canadian Medical Association Journal, 169(7), 656–661.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2015). Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva, Switzerland: WHO.
   Google Scholar